Herbas VPB

Print
EN | LT
LT - IMMUNE-MODIFYING PARTICLES FOR THE TREATMENT OF INFLAMMATION
EN - IMMUNE-MODIFYING PARTICLES FOR THE TREATMENT OF INFLAMMATION

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/00 (2006.01)
A61K 9/0019 (2013.01)
A61K 39/39 (2006.01)
A61K 39/001 (2013.01)
A61K 39/00 (2006.01)
A61K 39/39 (2013.01)
A61K 31/01 (2006.01)
A61K 31/01 (2013.01)
A61K 31/74 (2013.01)
A61K 31/74 (2006.01)
A61K 31/765 (2013.01)
A61K 31/765 (2006.01)
G01N 33/6893 (2013.01)
A61K 31/78 (2006.01)
G01N2800/7095 (2013.01)
G01N 33/68 (2006.01)
A61P 1/04 (2006.01)
A61K2039/55555 (2013.01)
A61K 31/78 (2013.01)
A61P 3/10 (2006.01)
A61P 5/50 (2006.01)
A61P 1/04 (2018.01)
A61P 7/02 (2006.01)
A61P 11/02 (2018.01)
A61P 9/00 (2006.01)
A61P 11/06 (2018.01)
A61P 9/08 (2006.01)
A61P 17/00 (2018.01)
A61P 17/04 (2018.01)
A61P 11/02 (2006.01)
A61P 17/06 (2018.01)
A61P 11/06 (2006.01)
A61P 19/02 (2018.01)
A61P 17/00 (2006.01)
A61P 21/00 (2018.01)
A61P 17/04 (2006.01)
A61P 21/02 (2018.01)
A61P 17/06 (2006.01)
A61P 25/00 (2018.01)
A61P 25/28 (2018.01)
A61P 27/02 (2018.01)
A61P 29/00 (2018.01)
A61P 31/04 (2018.01)
A61P 31/12 (2018.01)
A61P 31/14 (2018.01)
A61P 31/16 (2018.01)
A61P 31/20 (2018.01)
A61P 31/22 (2018.01)
A61P 37/06 (2018.01)
A61P 37/08 (2018.01)
A61P 43/00 (2018.01)
A61P 5/50 (2018.01)
A61P 7/02 (2018.01)
A61P 9/00 (2018.01)
A61P 9/08 (2018.01)
A61P 3/10 (2018.01)
Y02A 50/30 (2018.01)
European patent
(11) Number of the document 3494966
(13) Kind of document T
(96) European patent application number 18192279.0
Date of filing the European patent application 2014-03-13
(97) Date of publication of the European application 2019-06-12
(45) Date of publication and mention of the grant of the patent 2024-04-03
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
201361779182 P 2013-03-13 US
201361844961 P 2013-07-11 US
201361865392 P 2013-08-13 US
201361887212 P 2013-10-04 US
Inventors
(72)
KING, Nicholas , AU
GETTS, Daniel , US
Grantee
(73) onCOUR Pharma, Inc. , 2215 Sanders Road Suite 428, Northbrook, IL 60062, US
Title
(54) IMMUNE-MODIFYING PARTICLES FOR THE TREATMENT OF INFLAMMATION
  IMMUNE-MODIFYING PARTICLES FOR THE TREATMENT OF INFLAMMATION